LONDON (Reuters) - Pharmaceutical company Shire said it would work with a specialist cystic fibrosis foundation on developing a technology to improve patients' lung function and reduce infections. The collaboration was announced as the group showed off its drug development pipeline, with an update on products it predicts will help to generate $3 billion of new sales by 2020. ... via Health News Headlines - Yahoo News Read More Here..
No comments:
Post a Comment